Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Jan;63(1):82–87. doi: 10.1128/iai.63.1.82-87.1995

Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases.

V M Gordon 1, K R Klimpel 1, N Arora 1, M A Henderson 1, S H Leppla 1
PMCID: PMC172960  PMID: 7806387

Abstract

Before intoxication can occur, anthrax toxin protective antigen (PA), Pseudomonas exotoxin A (PE), and diphtheria toxin (DT) must be activated by proteolytic cleavage at specific amino acid sequences. Previously, it was shown that PA and DT can be activated by furin. In Chinese hamster ovary (CHO) cells, wild-type (RKKR) and cleavage site mutants of PA, each administered with a modified form of anthrax toxin lethal factor (the N terminus of lethal factor fused to PE domain III), had the following potencies: RKKR (wild type) (concentration causing 50% cell death [EC50] = 12 ng/ml) > or = RAAR (EC50 = 18 ng/ml) > FTKR (EC50 = 24 ng/ml) > STRR (EC50 = 49 ng/ml). In vitro cleavage of PA and cleavage site mutants of PA by furin demonstrated that native PA (RKKR) and PA with the cleavage sequence RAAR are substrates for furin. To characterize eukaryotic proteases that play a role in activating bacterial toxins, furin-deficient CHO cells were selected after chemical mutagenesis. Furin-deficient cells were resistant to PE, whose cleavage site, RQPR, constitutes a furin recognition site and to all PA cleavage site mutants, but were sensitive to DT (EC50 = 2.9 ng/ml) and PA (EC50 = 23 ng/ml), whose respective cleavage sites, RKKR and RVRR, contain additional basic residues. Furin-deficient cells that were transfected with the furin gene regained sensitivity to PE and PA cleavage site mutants. These studies provide evidence that furin can activate the three toxins and that one or more additional proteases contribute to the activation of DT and PA.

Full Text

The Full Text of this article is available as a PDF (284.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arora N., Klimpel K. R., Singh Y., Leppla S. H. Fusions of anthrax toxin lethal factor to the ADP-ribosylation domain of Pseudomonas exotoxin A are potent cytotoxins which are translocated to the cytosol of mammalian cells. J Biol Chem. 1992 Aug 5;267(22):15542–15548. [PubMed] [Google Scholar]
  2. Barr P. J. Mammalian subtilisins: the long-sought dibasic processing endoproteases. Cell. 1991 Jul 12;66(1):1–3. doi: 10.1016/0092-8674(91)90129-m. [DOI] [PubMed] [Google Scholar]
  3. Brakch N., Rholam M., Boussetta H., Cohen P. Role of beta-turn in proteolytic processing of peptide hormone precursors at dibasic sites. Biochemistry. 1993 May 11;32(18):4925–4930. doi: 10.1021/bi00069a029. [DOI] [PubMed] [Google Scholar]
  4. Breslin M. B., Lindberg I., Benjannet S., Mathis J. P., Lazure C., Seidah N. G. Differential processing of proenkephalin by prohormone convertases 1(3) and 2 and furin. J Biol Chem. 1993 Dec 25;268(36):27084–27093. [PubMed] [Google Scholar]
  5. Bresnahan P. A., Leduc R., Thomas L., Thorner J., Gibson H. L., Brake A. J., Barr P. J., Thomas G. Human fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-beta-NGF in vivo. J Cell Biol. 1990 Dec;111(6 Pt 2):2851–2859. doi: 10.1083/jcb.111.6.2851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chaudhary V. K., Jinno Y., FitzGerald D., Pastan I. Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity. Proc Natl Acad Sci U S A. 1990 Jan;87(1):308–312. doi: 10.1073/pnas.87.1.308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cieplak W., Hasemann C., Eidels L. Specific cleavage of diphtheria toxin by human urokinase. Biochem Biophys Res Commun. 1988 Dec 15;157(2):747–754. doi: 10.1016/s0006-291x(88)80313-9. [DOI] [PubMed] [Google Scholar]
  8. Creemers J. W., Groot Kormelink P. J., Roebroek A. J., Nakayama K., Van de Ven W. J. Proprotein processing activity and cleavage site selectivity of the Kex2-like endoprotease PACE4. FEBS Lett. 1993 Dec 20;336(1):65–69. doi: 10.1016/0014-5793(93)81610-c. [DOI] [PubMed] [Google Scholar]
  9. Fitzgerald D. J., Fryling C. M., Zdanovsky A., Saelinger C. B., Kounnas M., Strickland D. K., Leppla S. Selection of Pseudomonas exotoxin-resistant cells with altered expression of alpha 2MR/LRP. Ann N Y Acad Sci. 1994 Sep 10;737:138–144. doi: 10.1111/j.1749-6632.1994.tb44307.x. [DOI] [PubMed] [Google Scholar]
  10. Friedlander A. M. Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process. J Biol Chem. 1986 Jun 5;261(16):7123–7126. [PubMed] [Google Scholar]
  11. Fryling C., Ogata M., FitzGerald D. Characterization of a cellular protease that cleaves Pseudomonas exotoxin. Infect Immun. 1992 Feb;60(2):497–502. doi: 10.1128/iai.60.2.497-502.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gordon V. M., Leppla S. H., Hewlett E. L. Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin. Infect Immun. 1988 May;56(5):1066–1069. doi: 10.1128/iai.56.5.1066-1069.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gordon V. M., Leppla S. H. Proteolytic activation of bacterial toxins: role of bacterial and host cell proteases. Infect Immun. 1994 Feb;62(2):333–340. doi: 10.1128/iai.62.2.333-340.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hatsuzawa K., Nagahama M., Takahashi S., Takada K., Murakami K., Nakayama K. Purification and characterization of furin, a Kex2-like processing endoprotease, produced in Chinese hamster ovary cells. J Biol Chem. 1992 Aug 15;267(23):16094–16099. [PubMed] [Google Scholar]
  15. Jinno Y., Ogata M., Chaudhary V. K., Willingham M. C., Adhya S., FitzGerald D., Pastan I. Domain II mutants of Pseudomonas exotoxin deficient in translocation. J Biol Chem. 1989 Sep 25;264(27):15953–15959. [PubMed] [Google Scholar]
  16. Klimpel K. R., Molloy S. S., Thomas G., Leppla S. H. Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10277–10281. doi: 10.1073/pnas.89.21.10277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kounnas M. Z., Morris R. E., Thompson M. R., FitzGerald D. J., Strickland D. K., Saelinger C. B. The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds and internalizes Pseudomonas exotoxin A. J Biol Chem. 1992 Jun 25;267(18):12420–12423. [PubMed] [Google Scholar]
  18. Leppla S. H. Production and purification of anthrax toxin. Methods Enzymol. 1988;165:103–116. doi: 10.1016/s0076-6879(88)65019-1. [DOI] [PubMed] [Google Scholar]
  19. Misumi Y., Oda K., Fujiwara T., Takami N., Tashiro K., Ikehara Y. Functional expression of furin demonstrating its intracellular localization and endoprotease activity for processing of proalbumin and complement pro-C3. J Biol Chem. 1991 Sep 5;266(25):16954–16959. [PubMed] [Google Scholar]
  20. Moehring J. M., Inocencio N. M., Robertson B. J., Moehring T. J. Expression of mouse furin in a Chinese hamster cell resistant to Pseudomonas exotoxin A and viruses complements the genetic lesion. J Biol Chem. 1993 Feb 5;268(4):2590–2594. [PubMed] [Google Scholar]
  21. Moehring J. M., Moehring T. J. Strains of CHO-K1 cells resistant to Pseudomonas exotoxin A and cross-resistant to diphtheria toxin and viruses. Infect Immun. 1983 Sep;41(3):998–1009. doi: 10.1128/iai.41.3.998-1009.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Molloy S. S., Bresnahan P. A., Leppla S. H., Klimpel K. R., Thomas G. Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem. 1992 Aug 15;267(23):16396–16402. [PubMed] [Google Scholar]
  23. Moskaug J. O., Sletten K., Sandvig K., Olsnes S. Translocation of diphtheria toxin A-fragment to the cytosol. Role of the site of interfragment cleavage. J Biol Chem. 1989 Sep 15;264(26):15709–15713. [PubMed] [Google Scholar]
  24. Nakayama K., Watanabe T., Nakagawa T., Kim W. S., Nagahama M., Hosaka M., Hatsuzawa K., Kondoh-Hashiba K., Murakami K. Consensus sequence for precursor processing at mono-arginyl sites. Evidence for the involvement of a Kex2-like endoprotease in precursor cleavages at both dibasic and mono-arginyl sites. J Biol Chem. 1992 Aug 15;267(23):16335–16340. [PubMed] [Google Scholar]
  25. Ogata M., Fryling C. M., Pastan I., FitzGerald D. J. Cell-mediated cleavage of Pseudomonas exotoxin between Arg279 and Gly280 generates the enzymatically active fragment which translocates to the cytosol. J Biol Chem. 1992 Dec 15;267(35):25396–25401. [PubMed] [Google Scholar]
  26. Ohnishi Y., Shioda T., Nakayama K., Iwata S., Gotoh B., Hamaguchi M., Nagai Y. A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1. J Virol. 1994 Jun;68(6):4075–4079. doi: 10.1128/jvi.68.6.4075-4079.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Quinn C. P., Singh Y., Klimpel K. R., Leppla S. H. Functional mapping of anthrax toxin lethal factor by in-frame insertion mutagenesis. J Biol Chem. 1991 Oct 25;266(30):20124–20130. [PubMed] [Google Scholar]
  28. Rehemtulla A., Barr P. J., Rhodes C. J., Kaufman R. J. PACE4 is a member of the mammalian propeptidase family that has overlapping but not identical substrate specificity to PACE. Biochemistry. 1993 Nov 2;32(43):11586–11590. doi: 10.1021/bi00094a015. [DOI] [PubMed] [Google Scholar]
  29. Rehemtulla A., Kaufman R. J. Preferred sequence requirements for cleavage of pro-von Willebrand factor by propeptide-processing enzymes. Blood. 1992 May 1;79(9):2349–2355. [PubMed] [Google Scholar]
  30. Salminen A., Gottesman M. M. Inhibitor studies indicate that active cathepsin L is probably essential to its own processing in cultured fibroblasts. Biochem J. 1990 Nov 15;272(1):39–44. doi: 10.1042/bj2720039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sandvig K., Olsnes S. Rapid entry of nicked diphtheria toxin into cells at low pH. Characterization of the entry process and effects of low pH on the toxin molecule. J Biol Chem. 1981 Sep 10;256(17):9068–9076. [PubMed] [Google Scholar]
  32. Seetharam S., Chaudhary V. K., FitzGerald D., Pastan I. Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL. J Biol Chem. 1991 Sep 15;266(26):17376–17381. [PubMed] [Google Scholar]
  33. Singh Y., Chaudhary V. K., Leppla S. H. A deleted variant of Bacillus anthracis protective antigen is non-toxic and blocks anthrax toxin action in vivo. J Biol Chem. 1989 Nov 15;264(32):19103–19107. [PubMed] [Google Scholar]
  34. Tsuneoka M., Nakayama K., Hatsuzawa K., Komada M., Kitamura N., Mekada E. Evidence for involvement of furin in cleavage and activation of diphtheria toxin. J Biol Chem. 1993 Dec 15;268(35):26461–26465. [PubMed] [Google Scholar]
  35. Watanabe T., Murakami K., Nakayama K. Positional and additive effects of basic amino acids on processing of precursor proteins within the constitutive secretory pathway. FEBS Lett. 1993 Apr 12;320(3):215–218. doi: 10.1016/0014-5793(93)80589-m. [DOI] [PubMed] [Google Scholar]
  36. Watson D. G., Moehring J. M., Moehring T. J. A mutant CHO-K1 strain with resistance to Pseudomonas exotoxin A and alphaviruses fails to cleave Sindbis virus glycoprotein PE2. J Virol. 1991 May;65(5):2332–2339. doi: 10.1128/jvi.65.5.2332-2339.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Williams D. P., Wen Z., Watson R. S., Boyd J., Strom T. B., Murphy J. R. Cellular processing of the interleukin-2 fusion toxin DAB486-IL-2 and efficient delivery of diphtheria fragment A to the cytosol of target cells requires Arg194. J Biol Chem. 1990 Nov 25;265(33):20673–20677. [PubMed] [Google Scholar]
  38. Willnow T. E., Herz J. Genetic deficiency in low density lipoprotein receptor-related protein confers cellular resistance to Pseudomonas exotoxin A. Evidence that this protein is required for uptake and degradation of multiple ligands. J Cell Sci. 1994 Mar;107(Pt 3):719–726. [PubMed] [Google Scholar]
  39. Yoshida T., Chen C. C., Zhang M. S., Wu H. C. Disruption of the Golgi apparatus by brefeldin A inhibits the cytotoxicity of ricin, modeccin, and Pseudomonas toxin. Exp Cell Res. 1991 Feb;192(2):389–395. doi: 10.1016/0014-4827(91)90056-z. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES